FDA to host public meeting on testing methods for asbestos in talc

By Becky Bargh | Published: 4-Feb-2020

Following a flurry of talc-related lawsuits in the personal care sector, the FDA has been pressured into taking more responsibility for companies’ testing methods

You need to be a subscriber to read this article.
Click here to find out more.

Asbestos-contaminated talc is a repeated source of concern in the beauty sector.

Personal care giant Johnson & Johnson paid out US$4.7bn in damages to 22 complainants in 2018, and this is just one of the more high profile cases in recent years.

In response, the Food and Drug Administration (FDA) has been called to do more to ensure cosmetic companies are taking the appropriate action to ensure their talc is asbestos-free.

Speaking to Cosmetics Business, Michelle Whitmer, writer and Editor for Mesothelioma advocacy firm asbestos.com said:

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like